费纳斯特与主观记忆缺陷之间的关联:来自NHANES和FAERS数据库的研究
Hao Zhang1, Hongqi Ou1, Panli Zhao1
1Department of Pharmacy, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, China.
Frontiers in neurology
|June 30, 2025
概括
根据最新的研究,使用费纳斯特可能与记忆问题有关. 这项研究分析了健康数据和不良事件报告,表明需要提高对认知影响的认识和监测.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 市场营销后的数据表明,费纳斯特的潜在认知副作用.
- 现有关于费纳斯特和记忆功能障碍的研究显示出混合的结果.
- 需要进一步的临床研究来澄清这些认知影响.
研究的目的:
- 调查费纳斯特和自我报告的记忆功能障碍之间的关联.
- 建立一个以证据为基础的框架来确定费纳斯特的临床安全性.
- 为了帮助治疗费纳斯特的风险效益分析.
主要方法:
- 利用了来自国家健康和营养检查调查 (NHANES) 和FAERS的数据.
- 采用描述性统计,多变量逻辑回归和ROC曲线分析.
- 检查了费纳斯特暴露和认知表现指标之间的关联.
主要成果:
- 纳恩斯数据显示,费纳斯特和记忆障碍之间存在显著的正相关性 (aOR=6.15).
- 在FAERS数据库中报告了526例认知功能障碍病例,其中有6624例与费纳斯特相关的不良事件.
- 趋同的证据表明,费纳斯特和与记忆相关的认知问题之间存在联系.
结论:
- 流行病学和药监数据表明,可能存在费纳斯特与认知功能障碍的关联.
- 强调需要关于神经认知影响的风险沟通.
- 建议对长期治疗费纳斯特的患者进行常规认知监测.
更多相关视频
04:58Rapid Golgi Stain for Dendritic Spine Visualization in Hippocampus and Prefrontal Cortex
Published on: December 3, 2021
6.7K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.1K
相关概念视频
Amnesia
201
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
201
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
213
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
213
